Fibroid growth in response to high-dose progestogen.
To challenge the conventional belief that leiomyomata are estrogen-dependent tumors by presentation of a case report suggesting high-dose progestogen therapy is associated with a dramatic increase in size of a fibroid uterus. Case report. British university hospital. One white woman treated with tamoxifen and high-dose megestrol acetate for breast carcinoma. Megestrol acetate therapy withdrawn. Uterine size. While taking tamoxifen and high-dose megestrol acetate, the patient suffered a dramatic increase in size of her fibroid uterus, which reversed when the progestogen was withdrawn. This case report suggests that P may be important in fibroid growth.